Americana Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4M | Buy |
271,762
+1,592
| +0.6% | +$296K | 1.74% | 9 |
|
|
2025
Q1 | $56.6M | Sell |
270,170
-2,049
| -0.8% | -$429K | 2.2% | 5 |
|
|
2024
Q4 | $48.4M | Buy |
272,219
+198,647
| +270% | +$35.3M | 1.97% | 6 |
|
|
2024
Q3 | $14.5M | Buy |
73,572
+2,358
| +3% | +$466K | 0.99% | 26 |
|
|
2024
Q2 | $12.2M | Buy |
71,214
+1,021
| +1% | +$175K | 0.96% | 26 |
|
|
2024
Q1 | $12.8M | Sell |
70,193
-1,632
| -2% | -$297K | 1.07% | 22 |
|
|
2023
Q4 | $11.2M | Buy |
71,825
+17,900
| +33% | +$2.79M | 1.07% | 22 |
|
|
2023
Q3 | $7.99M | Buy |
53,925
+1,800
| +3% | +$267K | 0.86% | 27 |
|
|
2023
Q2 | $7.02M | Buy |
52,125
+2,316
| +5% | +$312K | 0.9% | 27 |
|
|
2023
Q1 | $7.94M | Buy |
49,809
+13
| +0% | +$2.07K | 1.25% | 17 |
|
|
2022
Q4 | $8.05M | Sell |
49,796
-14,867
| -23% | -$2.4M | 1.39% | 16 |
|
|
2022
Q3 | $8.67M | Buy |
64,663
+18,747
| +41% | +$2.51M | 1.55% | 12 |
|
|
2022
Q2 | $6.91M | Buy |
45,916
+30,290
| +194% | +$4.56M | 1.24% | 17 |
|
|
2022
Q1 | $2.47M | Sell |
15,626
-19,150
| -55% | -$3.02M | 0.76% | 29 |
|
|
2021
Q4 | $4.71M | Buy |
34,776
+19,334
| +125% | +$2.62M | 0.86% | 30 |
|
|
2021
Q3 | $1.67M | Buy |
+15,442
| New | +$1.67M | 0.4% | 61 |
|
|
2020
Q2 | – | Sell |
-2,762
| Closed | -$210K | – | 92 |
|
|
2020
Q1 | $210K | Buy |
2,762
+2,400
| +663% | +$182K | 0.21% | 91 |
|
|
2019
Q4 | $32K | Buy |
+362
| New | +$32K | 0.02% | 281 |
|